Orthopediatrics (KIDS) Net Cash Flow Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | 25.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.13% |
| Dec 31, 2025 | 138.50% |
| Sep 30, 2025 | -229.02% |
| Jun 30, 2025 | 15.61% |
| Mar 31, 2025 | 6.15% |
| Dec 31, 2024 | -135.11% |
| Sep 30, 2024 | 2,082.01% |
| Jun 30, 2024 | 137.90% |
| Mar 31, 2024 | -142.39% |
| Dec 31, 2023 | 174.30% |
| Sep 30, 2023 | 157.58% |
| Jun 30, 2023 | -229.12% |
| Mar 31, 2023 | 156.26% |
| Dec 31, 2022 | -1,668.57% |
| Sep 30, 2022 | 56.61% |
| Jun 30, 2022 | 277.73% |
| Mar 31, 2022 | 234.45% |
| Dec 31, 2021 | 102.86% |
| Sep 30, 2021 | 84.01% |
| Jun 30, 2021 | -118.04% |
| Mar 31, 2021 | 56.21% |
| Dec 31, 2020 | -214.66% |
| Sep 30, 2020 | -1,340.53% |
| Jun 30, 2020 | 294.66% |
| Mar 31, 2020 | -116.10% |
| Dec 31, 2019 | 42.58% |
| Sep 30, 2019 | 16.30% |
| Jun 30, 2019 | -277.93% |
| Mar 31, 2019 | 0.93% |
| Dec 31, 2018 | -10.20% |
| Sep 30, 2018 | -51,175.00% |
| Jun 30, 2018 | -3,713.68% |
| Mar 31, 2018 | -1,054.72% |
| Dec 31, 2017 | 13,622.45% |